Horizon Therapeutics

KRYSTEXXA - Cost

Last Updated: April 1st, 2024

HCPCS:

J2507

HCPCS Code Descriptor:

Injection, pegloticase, 1 mg

Medicare Payment Limit:

The KRYSTEXXA Medicare Payment Limit is $3391.914

Average Sale Price:

KRYSTEXXA ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The KRYSTEXXA Medicare Co-insurance percentage is 20%. KRYSTEXXA's Medicare Co-insurance amount is $678.38 per HCPCS unit.

APC Code:

The Krystexxa APC Code is: 9281

APC Payment Limit:

The APC Payment Limit for KRYSTEXXA is available. Login to view.

Krystexxa Cost Information:

KRYSTEXXA, a product of Horizon Therapeutics, became effective on January 1, 2012, and is associated with HCPCS J2507. Between 2020 and 2024, prices have trended upwards increasing every six months on average. ASP experienced a substantial increase of over 40% during this time period.

ACCESS PRICING AND MORE BY REGISTERING

Krystexxa’s wholesale acquisition cost (WAC) information was last updated on:
February 2, 2024
Krystexxa’s average wholesale price (AWP) information was last updated on:
February 2, 2024